In Brief: Federal Trade Commission hearing
Executive Summary
Federal Trade Commission hearing: On "how pharmaceutical research is changing to provide more competition with brand name drugs" will occur Oct. 23. The hearing is part of a series on whether "changing economic factors such as globalization and the growth of high-tech industries" necessitate adjustments to FTC's antitrust and consumer protection enforcement policies. The hearing will take place at FTC headquarters in Washington, D.C...